Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (16)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
The number of new psychoactive substances (NPS) has increased significantly, especially within the last 5 years. The EMCDDA conducts risks assessments of such substances, especially in relation to serious adverse events. Examination of the indiv[...]
Article : Périodique
J. MOUNTENEY ; P. GRIFFITHS ; A. CUNNINGHAM ; M. EVANS-BROWN ; M. FERRI ; D. HEDRICH ; A. NOOR |May 2016 saw the launch of the European Drug Report (EDR), the European Monitoring Centre for Drugs and Drug Addiction's (EMCDDA) annual review of the European drug situation, incorporating situational and trend analysis, statistical data and in[...]
Rapport
These guidelines provide the rationale, steps, procedures, roles, and responsibilities for the operation of the EU Early Warning System. They reflect the requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 20[...]
Rapport
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. CHRISTIE ; S. SOLA ; A. ALMEIDA ; R. JORGE ; J. DE MORAIS ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2018In this update from the EU Early Warning System, the EMCDDA aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency's early warning and risk-assessment activities. This report cov[...]
Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; M. EVANS-BROWN ; I. GIRAUDON | Lisbon : OEDT / EMCDDA | Technical reports | 2012The EMCDDA Trendspotter case study on Fentanyl in Europe was undertaken during September and October 2012. It culminated in an expert meeting in Lisbon on 9-10 October 2012. The aim of the study was to increase understanding of the availability [...]![Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age [Editorial]](https://bdoc.ofdt.fr/img_cache/4d07379d4df3a3ba9682936067c122eb.png)
Article : Périodique
There is a need to review the various regulatory options that are available in order to address the challenge presented by a plethora of new psychoactive substances appearing on the market as well as to address the technology for rapid developme[...]
Article : Périodique
ENGLISH : Injectable human growth hormone has been used as a performance-enhancing drug in the United Kingdom since at least the mid-1980s. However, because of its prohibitive cost and limited supply it was initially restricted to a relatively[...]![Isotonitazene. Report on the risk assessment of N,N-diethyl-2- [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole- 1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)](https://bdoc.ofdt.fr/img_cache/b4318b391eb0bf234e8927bead1c3c06.png)
Rapport
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. SEDEFOV ; A. ALMEIDA ; R. CHRISTIE ; P. DUQUE ; A. GALLEGOS ; R. JORGE ; J. DE MORAIS | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2020This publication presents the data and findings of the risk assessment on N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1- ethanamine (isotonitazene), carried out by the extended Scientific Committee of the EMCDDA on [...]
Rapport
OEDT = EMCDDA ; V. AUWÄRTER ; J. DE MORAIS ; A. GALLEGOS ; M. EVANS-BROWN ; R. CHRISTIE ; R. JORGE ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2021This report provides a technical review of the current body of knowledge regarding new benzodiazepines that are monitored by the EU Early Warning System. The aims of this report are to strengthen situational awareness of new benzodiazepines in E[...]
Rapport
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. CHRISTIE ; R. JORGE ; J. DE MORAIS ; A. ALMEIDA ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2020In this update from the the EU Early Warning System aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency's early warning and risk-assessment activities. The report covers the p[...]
Rapport
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; W. FRANCIS ; R. CHRISTIE ; A. CUNNINGHAM ; J. SEKULA ; A. ALMEIDA ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2015FRANÇAIS : De nouvelles substances psychoactives (NSP ou «nouvelles drogues») ont été détectées dans l'Union européenne l'année dernière au rythme de deux par semaine environ. Au total, 101 nouvelles substances ont été signalées au système d'al[...]
Rapport
This short report provides an overview of how European countries are developing innovative legal responses to the challenges presented to public health and drug policy by the rapidly evolving market for new psychoactive substances.
Rapport
OEDT = EMCDDA ; L. VAN AERTS ; J. DE MORAIS ; M. EVANS-BROWN ; R. JORGE ; A. GALLEGOS ; R. CHRISTIE ; T. NÉFAU ; G. PLANCHUELO ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2022The purpose of this report is to examine the current situation, risks and responses to the recreational use of nitrous oxide in Europe. To support this, the report also provides a state-of-the-art review of the chemistry, pharmacology and toxico[...]
Rapport
L. JONES ; G. BATES ; M. BELLIS ; C. BEYNON ; P. DUFFY ; M. EVANS-BROWN ; A. J. MACKRIDGE ; E. McCOY ; H. SUMNALL ; J. McVEIGH | London : National Treatment Agency for Substance Misuse (NTA) | 2011FRANÇAIS : Ce rapport s'intéresse aux dommages sur la santé physique et mentale causés par la consommation de drogues. Il prend principalement la forme de tableaux donnant, pour chacune des substances étudiées, les effets liés à une consommatio[...]
Rapport
OEDT = EMCDDA ; V. AUWÄRTER ; J. DE MORAIS ; A. GALLEGOS ; M. EVANS-BROWN ; R. CHRISTIE ; R. JORGE ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Technical reports | 2021This report provides a technical review of the current body of knowledge regarding synthetic cannabinoids that are monitored by the EU Early Warning System. The aim of this report is to strengthen situational awareness of synthetic cannabinoids [...]
